Jaguar动物健康 JAGX 深 沪
等待开盘 04-02 09:30:00 美东时间
0.41
+0.040
+10.66%
华盛通- 最 高0.48
- 今 开0.37
- 成交量 77.28万股
- 最 低 0.37
- 昨 收 0.3705
- 总市值 509.19万
- 52周最高 15.48
- 市盈率 静 --
- 换手率 6.22%
- 52周最低 0.313
- 委 比 33.33%
- 总股本 1241.93万
- 历史最高 2501887500.00
- 量 比 4.32
- 振 幅 29.69%
- 历史最低 0.313
- 每 手 1
- 风险率 2.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares rose 307.1% to $6.31 durin...
今天 01:06
Jaguar Health's Napo Pharma Receives $3M Payment From Future Pak Following Termination By Jaguar Of Buy-Back Provision Of U.S. Licensing Agreement; Future Pak To Continue To Commercialize Mytesi Beyond Five Years
As announced, Jaguar received an up-front payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's two
03-03 22:05
Jaguar Health Receives $3 Million Payment From Future Pak for Mytesi and Canalevia-CA1 License Deal
Jaguar Health Receives $3 Million Payment From Future Pak for Mytesi and Canalevia-CA1 License Deal Jaguar Health said it received a $3 million payment from Future Pak after terminating the buy-back provision in their U.S. licensing agreement for Mytesi and Canalevia-CA1. The company said the termin
03-03 22:00
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers CASI Pharmaceuticals (NASDAQ:CASI) shares rose 54.2% to $0.32 during W...
02-26 05:07
Jaguar Health Announces One-Time Special Stock Dividend
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company") today announced that its Board of Directors has declared a one-time special stock dividend (the "Special Stock Dividend") to holders of Jaguar Common Stock
02-18 22:03
First Berlin Equity Research Sets Jaguar Health Price Target at $7.50 with Buy Rating
First Berlin Equity Research Sets Jaguar Health Price Target at $7.50 with Buy Rating First Berlin Equity Research has released an updated report on Jaguar Health Inc., reiterating its BUY recommendation while lowering the 12-month price target from USD 35.00 to USD 7.50. Analyst Christian Orquera c
02-12 22:47
Jaguar Health Reduces Debt Through Equity Exchange with Iliad
Jaguar Health Reduces Debt Through Equity Exchange with Iliad Jaguar Health Inc. announced it has entered into privately negotiated exchange agreements with Iliad Research and Trading, L.P. and Streeterville, involving the exchange of outstanding royalty interests and preferred stock for pre-funded
01-26 15:44
Jaguar Health Executes Debt-Reducing Equity Warrant Transactions
An update from Jaguar Animal Health ( ($JAGX) ) is now available. On January 16...
01-24 06:26
Why Rapt Therapeutics Shares Are Trading Higher By 63%; Here Are 20 Stocks Moving Premarket
Shares of Rapt Therapeutics Inc (NASDAQ:RAPT) rose sharply in pre-market tradin...
01-20 18:02
The Surge In Jaguar Health Stock: What's Happening Now?
Jaguar Health Inc (NASDAQ:JAGX) subsidiary, Napo Pharmaceuticals, has struck a new licensing deal with Woodward Specialty.
01-17 02:54
